Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

With the rapid increase in provision of deep brain stimulation for Parkinson's disease, the efficacy of pallidotomy in symptom alleviation appears to be increasingly ignored. We demonstrate that lesional surgery is effective with benefit over a significant period of time with very significant societal cost savings. Such studies are essential for future planning of services so that maximum numbers of patients can benefit from surgery, both lesional and neuromodulation, as deemed appropriate.

Original publication




Journal article


J Clin Neurosci

Publication Date





829 - 834


Adult, Aged, Aged, 80 and over, Antiparkinson Agents, Cohort Studies, Costs and Cost Analysis, Female, Humans, Male, Middle Aged, Neurologic Examination, Pallidotomy, Parkinson Disease, Severity of Illness Index, Treatment Outcome